We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGGRU
1926
DELISTED
Agile Growth Corp Units
AGGRU
$4.84M ﹤0.01%
485,300
+313,652
+183% +$3.13M
NX icon
1927
Quanex
NX
$863M
$4.83M ﹤0.01%
194,650
-39,299
-17% -$1.05M
SKYW icon
1928
Skywest
SKYW
$4.37B
$4.83M ﹤0.01%
112,134
+14,823
+15% +$731K
FCAX
1929
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$4.82M ﹤0.01%
+489,962
New +$4.83M
LAD icon
1930
PUT
Lithia Motors
LAD
$7.88B
$4.81M ﹤0.01%
14,000
-9,100
-39% -$3.29M
EG icon
1931
Everest Group
EG
$15.4B
$4.81M ﹤0.01%
19,085
+3,798
+25% +$989K
CSGP icon
1932
PUT
CoStar Group
CSGP
$11.9B
$4.8M ﹤0.01%
58,000
+22,000
+61% +$1.9M
APGB.U
1933
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$4.8M ﹤0.01%
480,259
+89,526
+23% +$899K
EXEEL
1934
DELISTED
Expand Energy Corp Class C Warrants
EXEEL
$4.8M ﹤0.01%
230,136
ATRO icon
1935
Astronics
ATRO
$3.47B
$4.8M ﹤0.01%
328,903
-41,428
-11% -$601K
MDP
1936
CALL
DELISTED
Meredith Corporation
MDP
$4.79M ﹤0.01%
110,300
+60,500
+121% +$2.15M
WB icon
1937
PUT
Weibo
WB
$1.92B
$4.79M ﹤0.01%
91,000
TNDM icon
1938
PUT
Tandem Diabetes Care
TNDM
$1.18B
$4.76M ﹤0.01%
48,900
+28,900
+145% +$2.58M
HERAU
1939
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$4.75M ﹤0.01%
473,182
-24,703
-5% -$248K
PETQ
1940
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4.75M ﹤0.01%
123,055
-13,987
-10% -$558K
CHE icon
1941
CALL
Chemed
CHE
$6.76B
$4.75M ﹤0.01%
+10,000
New +$4.8M
CBZ icon
1942
CBIZ
CBZ
$2.39B
$4.74M ﹤0.01%
144,747
-120,997
-46% -$4.04M
TPGY
1943
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$4.74M ﹤0.01%
368,060
-191,376
-34% -$2.77M
ACRS icon
1944
Aclaris Therapeutics
ACRS
$750M
$4.73M ﹤0.01%
+269,255
New +$6.12M
UA icon
1945
PUT
Under Armour Class C
UA
$2.95B
$4.73M ﹤0.01%
254,500
+117,700
+86% +$2.22M
ATHN.U
1946
DELISTED
Athena Technology Acquisition Corp. Units, each consisting of one share of Class A Common Stock and
ATHN.U
$4.72M ﹤0.01%
473,677
+207,011
+78% +$2.07M
IBOC icon
1947
International Bancshares
IBOC
$4.77B
$4.71M ﹤0.01%
109,781
+611
+0.6% +$28.5K
LDTC
1948
DELISTED
LeddarTech
LDTC
$4.71M ﹤0.01%
+971,670
New +$4.75M
BHC icon
1949
Bausch Health
BHC
$1.67B
$4.71M ﹤0.01%
160,491
+145,458
+968% +$4.41M
CADE
1950
DELISTED
Cadence Bank
CADE
$4.71M ﹤0.01%
166,064
+87,182
+111% +$2.64M

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.